Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Anemia Drugs Market Research Reports

Titlepublishedprice

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... across the globe. A key objective of the Acquired (Autoimmune) Hemolytic Anemia Report is to understand the market and pipeline status of the drugs around the Acquired (Autoimmune) Hemolytic Anemia to explore the generic development opportunities, li......"
01-Sep-2016$2000

Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... e of the Anemia Report is to understand the market and pipeline status of the drugs around the Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The De......"
01-Sep-2016$2000

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... . A key objective of the Iron Deficiency Anemia Report is to understand the market and pipeline status of the drugs around the Iron Deficiency Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive ad......"
01-Sep-2016$2000

Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... A key objective of the Megaloblastic Anemia Report is to understand the market and pipeline status of the drugs around the Megaloblastic Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantag......"
01-Sep-2016$2000

Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ey objective of the Pernicious Anemia Report is to understand the market and pipeline status of the drugs around the Pernicious Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on desi......"
01-Sep-2016$2000

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ey objective of the Refractory Anemia Report is to understand the market and pipeline status of the drugs around the Refractory Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on desi......"
01-Sep-2016$2000

Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... jective of the Renal Anemia Report is to understand the market and pipeline status of the drugs around the Renal Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......"
01-Sep-2016$2000

Iron Deficiency Anemia - Pipeline Review, H2 2016

By Global Markets Direct
"...... by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and lat......"
20-Jul-2016$2000

Global Anemia Partnering 2010 to 2016

By Current Partnering
"...... Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed ......"
01-Jul-2016$1495

Aplastic Anemia - Pipeline Review, H1 2016

By Global Markets Direct
"...... nt, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press re......"
31-May-2016$2000